Table 2.
Baseline characteristics
| Variable name: mean (SD) (minimum, maximum) | TURP, n=24 | PVP, n=140 | p value |
|---|---|---|---|
| Age (years) | 70.8 (7.6) (55, 82) | 67.4 (7.6) (48, 85) | 0.045 |
| Prostate size (cc) | 54.5 (20.5) (19, 90) | 48.0 (18.8) (20, 102) | 0.123 |
| Prostate volume (cc) | 54.5 (22.4) (19, 99) | 53.8 (26.2) (14, 152) | 0.900 |
| Maximum flow rate (Qmax) (mL/sec) | 8.8 (4.4) (2.9, 18.4) | 11.0 (4.2) (2.0, 29.8) | 0.017 |
| Average flow rate (mL/sec) | 4.7 (2.3) (1.7, 9.4) | 5.6 (2.2) (1.4, 13.2) | 0.066 |
| Total voiding duration (sec) | 58.9 (52.5) (9.0, 263.0) | 51.7 (30.4) (15.0, 219.0) | 0.345 |
| Postvoid residual volume (mL) | 68.8 (69.1) (0, 233) | 106.9 (108.5) (0, 395) | 0.114 |
| PSA (ng/dL) | 3.0 (2.1) (0.4, 9.1) | 2.9 (2.5) (0.2, 13.4) | 0.782 |
| Use of 5-alpha reductase inhibitors (%) | 11 (46%) | 50 (36%) | 0.367 |
| Use of alpha blockers (%) | 20 (83%) | 101 (72%) | 0.320 |
| Both alpha and 5-alpha | 8 (33%) | 35 (25%) | 0.452 |
| Employment status (FT or PT) | 5 (21%) | 51 (36%) | 0.137 |
TURP: transurethral resection of the prostate; PVP: photoselective vaporization of the prostate; SD: standard deviation; PSA: prostate-specific antigen; FT: full time; PT: part time. Values are reported as mean (SD) (minimum, maximum), or n (%).